We are live on ! Find out more
QURE icon

uniQure

178 hedge funds and large institutions have $912M invested in uniQure in 2022 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 51 increasing their positions, 63 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

318% more call options, than puts

Call options by funds: $57.7M | Put options by funds: $13.8M

82% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 22

67% more funds holding in top 10

Funds holding in top 10: 35 (+2)

20% more capital invested

Capital invested by funds: $759M → $912M (+$153M)

10% more funds holding

Funds holding: 162178 (+16)

4.04% less ownership

Funds ownership: 90%85.96% (-4%)

19% less repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 63

Holders
178
Holders Change
+16
Holders Change %
+9.88%
% of All Funds
2.86%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.08%
New
40
Increased
51
Reduced
63
Closed
22
Calls
$57.7M
Puts
$13.8M
Net Calls
+$43.9M
Net Calls Change
+$14M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$113M +$1.72M +79,530 +2%
State Street
2
State Street
Massachusetts
$61.6M -$7.45M -345,389 -11%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$61.2M -$514K -23,830 -0.9%
NCM
4
Nantahala Capital Management
Connecticut
$61.2M -$4.35M -201,690 -7%
PHS
5
PFM Health Sciences
California
$52.2M -$1.96M -90,997 -4%
O
6
OrbiMed
New York
$39.6M +$3.25M +150,555 +9%
Point72 Asset Management
7
Point72 Asset Management
Connecticut
$37.9M -$55.8M -2,587,056 -61%
Vanguard Group
8
Vanguard Group
Pennsylvania
$32M -$486K -22,543 -2%
6CM
9
683 Capital Management
New York
$26M -$4.93M -228,600 -17%
Morgan Stanley
10
Morgan Stanley
New York
$24.1M +$1.63M +75,429 +8%
MB
11
MPM BioImpact
Massachusetts
$21.3M +$20.3M +939,966 New
Norges Bank
12
Norges Bank
Norway
$17.5M +$3.36M +155,907 +25%
Millennium Management
13
Millennium Management
New York
$17M +$16.1M +748,060 New
Macquarie Group
14
Macquarie Group
Australia
$16M -$7.42K -344 -0%
JP Morgan Chase
15
JP Morgan Chase
New York
$15.2M -$1.34M -62,055 -8%
TCM
16
Tekla Capital Management
Massachusetts
$14.8M +$2.82M +130,753 +25%
IBT
17
International Biotechnology Trust
United Kingdom
$14.3M +$1.88M +87,000 +16%
Adage Capital Partners
18
Adage Capital Partners
Massachusetts
$14.3M +$3.77M +175,000 +38%
ACM
19
Aquilo Capital Management
California
$14.2M -$4.67M -216,617 -26%
IHAM
20
Integral Health Asset Management
New York
$12.5M +$2.52M +117,000 +27%
AllianceBernstein
21
AllianceBernstein
Tennessee
$11.5M +$3.92M +181,791 +56%
Ameriprise
22
Ameriprise
Minnesota
$10.3M -$1.08M -49,884 -10%
Goldman Sachs
23
Goldman Sachs
New York
$9.89M -$740K -34,326 -7%
Geode Capital Management
24
Geode Capital Management
Massachusetts
$9.31M +$311K +14,405 +4%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$7.55M -$3.84K -178 -0.1%

QURE Hedge Fund Activity: Q4 2022 in Review

178 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in uniQure (QURE) for Q4 2022, worth a combined $912M — up 20% from $759M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new QURE positions and 22 closed out — a net gain of 18 holders — while 51 added to existing stakes and 63 trimmed.

The largest buyer was MPM BioImpact, opening a new position worth an estimated $20.3M. The largest seller was Point72 Asset Management, cutting an estimated $55.8M.

  • 178 institutional investors held uniQure (QURE) as of Q4 2022, up from 162 in Q3 2022.
  • Funds reported $912M of uniQure stock for Q4 2022, up 20% quarter-over-quarter.
  • 40 funds opened new uniQure positions in Q4 2022 and 22 closed out, a net change of +18 holders.
  • The largest uniQure buyer in Q4 2022 was MPM BioImpact, an estimated $20.3M added.
  • The largest uniQure seller in Q4 2022 was Point72 Asset Management, an estimated $55.8M sold.

Based on aggregated 13F filings for Q4 2022.